“The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients’ Quality of Life and the Role of Dermatologic Intervention”, Dermatol Pract Concept, vol. 14, no. 3, p. e2024118, Jul. 2024, doi: 10.5826/dpc.1403a118.